RCT part:
CareRA2020: Effectiveness of a combination of Methotrexate and a step down glucocorticoid regimen (COBRA-Slim) for remission induction in patients with early Rheumatoid Arthritis (RA), with or without fast access to 24 weeks of Tumor Necrosis Factor (TNF) blockade in insufficient responders, a randomized, multicenter, pragmatic trial.
LTE part:
CareRA2020 LTE: a 3 year longitudinal observational, multicenter, follow-up of early RA patients after participation in the CareRA2020 RCT.
CompletedCTIS2023-510189-28-00
UZ LeuvenRheumatoid Arthritis
Start: 2018-05-15End: 2025-07-08Target: 442Updated: 2024-02-01